FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289132007> ?p ?o ?g. }

• W4289132007 endingPage "1163" @default.
• W4289132007 startingPage "1153" @default.
• W4289132007 abstract "In tuberculosis (TB) treatment, adverse drug reactions (ADRs) can interrupt treatment and decrease the quality of life (QoL). We aimed to prospectively investigate the incidence of ADRs to first-line anti-TB drugs and related outcomes and QoL.Adult patients with TB who had been treated with first-line anti-TB drugs in five Korean hospitals were enrolled. ADR questionnaire surveys and blood tests were performed four times serially, and QoL was assessed on the fourth TB treatment week (±2 weeks).Of 410 enrolled patients with TB (males, 62%; mean age, 52.1 ± 18.1 years [those aged ≥65 years, 26.6%]), 67.8% experienced any ADRs (≥ grade 2) to TB drugs. The most common ADR was fatigue (53.2%), followed by itching (42.7%) and anorexia (41.7%). Older adult patients experienced relatively more ADRs, including anorexia, dyspepsia, rash, dizziness, anemia, abnormal hepatic/renal function tests, and increased uric acid levels (p < 0.05). Treatment regimens changed for 9.5% of patients owing to ADRs to anti-TB drugs. Patients with any ADRs and older adult patients had significantly lower QoL than their counterparts (p < 0.05). Old age (odds ratio [OR], 1.02) and being male (OR 2.65) were independently associated with ADRs, whereas active smoking (OR 4.73) and a relatively long treatment phase (OR 5.13) were independently associated with hepatotoxicity.ADRs to first-line anti-TB drugs were common and related to relatively low QoL, especially among older adults. Although 9.5% of patients had ADR-related regimen changes, most patients with ADRs completed treatments successfully." @default.
• W4289132007 created "2022-08-01" @default.
• W4289132007 creator A5000645096 @default.
• W4289132007 creator A5008706533 @default.
• W4289132007 creator A5019031360 @default.
• W4289132007 creator A5034626556 @default.
• W4289132007 creator A5034917040 @default.
• W4289132007 creator A5036157714 @default.
• W4289132007 creator A5042658735 @default.
• W4289132007 creator A5043853318 @default.
• W4289132007 creator A5046049570 @default.
• W4289132007 creator A5060718959 @default.
• W4289132007 creator A5067517882 @default.
• W4289132007 creator A5076277399 @default.
• W4289132007 creator A5077849701 @default.
• W4289132007 creator A5082596281 @default.
• W4289132007 date "2022-08-09" @default.
• W4289132007 modified "2023-10-06" @default.
• W4289132007 title "Incidence and outcomes of adverse drug reactions to first‐line anti‐tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study" @default.
• W4289132007 cites W1877158325 @default.
• W4289132007 cites W1989219811 @default.
• W4289132007 cites W1995803983 @default.
• W4289132007 cites W1998884492 @default.
• W4289132007 cites W2003268107 @default.
• W4289132007 cites W2057318709 @default.
• W4289132007 cites W2062243603 @default.
• W4289132007 cites W2069827761 @default.
• W4289132007 cites W2074352802 @default.
• W4289132007 cites W2100015029 @default.
• W4289132007 cites W2129047823 @default.
• W4289132007 cites W2154396724 @default.
• W4289132007 cites W2164907426 @default.
• W4289132007 cites W2246740579 @default.
• W4289132007 cites W2808693860 @default.
• W4289132007 cites W2898428094 @default.
• W4289132007 cites W2930106876 @default.
• W4289132007 cites W2948535403 @default.
• W4289132007 cites W2972642224 @default.
• W4289132007 cites W2998276385 @default.
• W4289132007 cites W3003605918 @default.
• W4289132007 cites W3014298010 @default.
• W4289132007 cites W3032980967 @default.
• W4289132007 cites W3044671634 @default.
• W4289132007 cites W3193142826 @default.
• W4289132007 cites W3197691555 @default.
• W4289132007 cites W4235935369 @default.
• W4289132007 doi "https://doi.org/10.1002/pds.5513" @default.
• W4289132007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35909258" @default.
• W4289132007 hasPublicationYear "2022" @default.
• W4289132007 type Work @default.
• W4289132007 citedByCount "2" @default.
• W4289132007 countsByYear W42891320072023 @default.
• W4289132007 crossrefType "journal-article" @default.
• W4289132007 hasAuthorship W4289132007A5000645096 @default.
• W4289132007 hasAuthorship W4289132007A5008706533 @default.
• W4289132007 hasAuthorship W4289132007A5019031360 @default.
• W4289132007 hasAuthorship W4289132007A5034626556 @default.
• W4289132007 hasAuthorship W4289132007A5034917040 @default.
• W4289132007 hasAuthorship W4289132007A5036157714 @default.
• W4289132007 hasAuthorship W4289132007A5042658735 @default.
• W4289132007 hasAuthorship W4289132007A5043853318 @default.
• W4289132007 hasAuthorship W4289132007A5046049570 @default.
• W4289132007 hasAuthorship W4289132007A5060718959 @default.
• W4289132007 hasAuthorship W4289132007A5067517882 @default.
• W4289132007 hasAuthorship W4289132007A5076277399 @default.
• W4289132007 hasAuthorship W4289132007A5077849701 @default.
• W4289132007 hasAuthorship W4289132007A5082596281 @default.
• W4289132007 hasConcept C120665830 @default.
• W4289132007 hasConcept C121332964 @default.
• W4289132007 hasConcept C126322002 @default.
• W4289132007 hasConcept C142724271 @default.
• W4289132007 hasConcept C156957248 @default.
• W4289132007 hasConcept C159110408 @default.
• W4289132007 hasConcept C187212893 @default.
• W4289132007 hasConcept C188816634 @default.
• W4289132007 hasConcept C197934379 @default.
• W4289132007 hasConcept C2778248108 @default.
• W4289132007 hasConcept C2778570526 @default.
• W4289132007 hasConcept C2779951463 @default.
• W4289132007 hasConcept C2781069245 @default.
• W4289132007 hasConcept C2781413609 @default.
• W4289132007 hasConcept C61511704 @default.
• W4289132007 hasConcept C71924100 @default.
• W4289132007 hasConcept C72563966 @default.
• W4289132007 hasConceptScore W4289132007C120665830 @default.
• W4289132007 hasConceptScore W4289132007C121332964 @default.
• W4289132007 hasConceptScore W4289132007C126322002 @default.
• W4289132007 hasConceptScore W4289132007C142724271 @default.
• W4289132007 hasConceptScore W4289132007C156957248 @default.
• W4289132007 hasConceptScore W4289132007C159110408 @default.
• W4289132007 hasConceptScore W4289132007C187212893 @default.
• W4289132007 hasConceptScore W4289132007C188816634 @default.
• W4289132007 hasConceptScore W4289132007C197934379 @default.
• W4289132007 hasConceptScore W4289132007C2778248108 @default.
• W4289132007 hasConceptScore W4289132007C2778570526 @default.
• W4289132007 hasConceptScore W4289132007C2779951463 @default.
• W4289132007 hasConceptScore W4289132007C2781069245 @default.
• W4289132007 hasConceptScore W4289132007C2781413609 @default.

• next